Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
Authors
Keywords
MAPK pathway, miRNA, Metabolic regulation, Migration, Apoptosis, Angiogenesis
Journal
LIFE SCIENCES
Volume 278, Issue -, Pages 119499
Publisher
Elsevier BV
Online
2021-04-16
DOI
10.1016/j.lfs.2021.119499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
- (2020) Shannon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer
- (2020) Shiva Najjary et al. GENE
- Development of MicroRNAs as Potential Therapeutics against Cancer
- (2020) Noraini Abd-Aziz et al. Journal of Oncology
- Covalent Inhibition in Drug Discovery
- (2019) Avick Kumar Ghosh et al. ChemMedChem
- MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer
- (2019) Maryam Hejazi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
- (2019) Braicu et al. Cancers
- ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy
- (2018) Bijay S. Jaiswal et al. CLINICAL CANCER RESEARCH
- MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells
- (2018) Di Chen et al. Frontiers in Pharmacology
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- The ERK and JNK pathways in the regulation of metabolic reprogramming
- (2018) Salvatore Papa et al. ONCOGENE
- Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
- (2017) Ursula A. Germann et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
- (2017) Xuerong Liu et al. ONCOLOGY REPORTS
- Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
- (2017) Davinder Singh et al. Cell and Bioscience
- Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes
- (2016) Kristin C. Hicks et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1
- (2016) O. A. Kent et al. MOLECULAR CANCER RESEARCH
- MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2
- (2016) Chuannan Fan et al. Oncotarget
- microRNA Therapeutics in Cancer — An Emerging Concept
- (2016) Maitri Y. Shah et al. EBioMedicine
- C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer
- (2015) D Sun et al. BRITISH JOURNAL OF CANCER
- Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center
- (2015) Justin M. Watts et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
- (2015) W. T. Iams et al. CLINICAL CANCER RESEARCH
- Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells
- (2015) Yanxia Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras
- (2015) Yantian Fang et al. MOLECULAR CARCINOGENESIS
- Cancer: The Ras renaissance
- (2015) Heidi Ledford NATURE
- miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer
- (2015) DONGLI ZHAO et al. ONCOLOGY REPORTS
- PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
- (2015) Valeria Iansante et al. Nature Communications
- RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
- (2015) Julien Masliah-Planchon et al. Oncotarget
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Determination of the invA gene of Salmonella using surface plasmon resonance along with streptavidin aptamer amplification
- (2014) Pinhua Lei et al. MICROCHIMICA ACTA
- MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase
- (2014) Jie Chai et al. TUMOR BIOLOGY
- Overexpression of miR-126 promotes the differentiation of mesenchymal stem cells toward endothelial cells via activation of PI3K/Akt and MAPK/ERK pathways and release of paracrine factors
- (2013) Feng Huang et al. BIOLOGICAL CHEMISTRY
- Targeting transcription factors
- (2013) Jennifer E. Yeh et al. CURRENT OPINION IN ONCOLOGY
- MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)
- (2013) Defang Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targetingKRAS,PIK3CDandBCL2
- (2013) Wen-Ting Liao et al. JOURNAL OF PATHOLOGY
- MEK in cancer and cancer therapy
- (2013) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation
- (2012) Haiyan Guo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma
- (2012) A Barbarulo et al. ONCOGENE
- MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
- (2011) Cheng You Jia et al. PLoS One
- Thelet-7microRNA reduces tumor growth in mouse models of lung cancer
- (2010) Aurora Esquela-Kerscher et al. CELL CYCLE
- RhoA can lead the way in tumor cell invasion and metastasis
- (2010) Amanda et al. Frontiers in Bioscience-Landmark
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA sponges: Progress and possibilities
- (2010) M. S. Ebert et al. RNA
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Phosphorylation of the Human MicroRNA-Generating Complex Mediates MAPK/Erk Signaling
- (2009) Zain Paroo et al. CELL
- Networking by small-molecule hormones in plant immunity
- (2009) Corné M J Pieterse et al. Nature Chemical Biology
- Regression of murine lung tumors by the let-7 microRNA
- (2009) P Trang et al. ONCOGENE
- LNA-mediated microRNA silencing in non-human primates
- (2008) Joacim Elmén et al. NATURE
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More